Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer

Autor: Boyd, Lenka N.C., Ali, Mahsoem, Puik, Jisce R., Comandatore, Annalisa, Ginocchi, Laura, Meijer, Laura L., Swijnenburg, Rutger-Jan, Tartarini, Roberta, Le Large, Tessa Y.S., Morelli, Luca, Garajova, Ingrid, Besselink, Marc G., Mambrini, Andrea, Wilmink, Johanna W., Frampton, Adam E., van Laarhoven, Hanneke W.M., Giovannetti, Elisa, Kazemier, Geert
Zdroj: In The Journal of Liquid Biopsy September 2024 5
Databáze: ScienceDirect